Ruifeng Chen

917 total citations · 1 hit paper
32 papers, 571 citations indexed

About

Ruifeng Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Ruifeng Chen has authored 32 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in Ruifeng Chen's work include Smoking Behavior and Cessation (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Obesity, Physical Activity, Diet (3 papers). Ruifeng Chen is often cited by papers focused on Smoking Behavior and Cessation (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Obesity, Physical Activity, Diet (3 papers). Ruifeng Chen collaborates with scholars based in United States, China and Singapore. Ruifeng Chen's co-authors include Karen Messer, David R. Strong, Eric C. Leas, John P. Pierce, Ying Min Low, Martha M. White, Tarik Benmarhnia, Dennis R. Trinidad, Matthew D. Stone and Sheila Kealey and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

Ruifeng Chen

31 papers receiving 563 citations

Hit Papers

Pembrolizumab plus cetuximab in patients with recurrent o... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
    2021 174 citations Assuntina G. Sacco, Ruifeng Chen et al. The Lancet Oncology profile →

Peers

Ruifeng Chen
Wojciech Dudek Poland
Sijian Zhang United States
Suren Krishnan Australia
Chengshui Chen China
Gordon McKenzie United Kingdom
Yuan Tan China
Man‐Yee Chan Taiwan
Kandice Mah Canada
Gary W. Chien United States
Chunpeng Fan United States
Wojciech Dudek Poland
Ruifeng Chen
Citations per year, relative to Ruifeng Chen Ruifeng Chen (= 1×) peers Wojciech Dudek

Countries citing papers authored by Ruifeng Chen

Since Specialization
Citations

This map shows the geographic impact of Ruifeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifeng Chen more than expected).

Fields of papers citing papers by Ruifeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruifeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifeng Chen. The network helps show where Ruifeng Chen may publish in the future.

Co-authorship network of co-authors of Ruifeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ruifeng Chen. A scholar is included among the top collaborators of Ruifeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruifeng Chen. Ruifeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Runfeng, Han Yu, Yanan Tong, et al.. (2024). Therapeutic effects of Lianhua Qingke on COPD and influenza virus-induced exacerbation of COPD are associated with the inhibition of NF-κB signaling and NLRP3 inflammasome responses. International Immunopharmacology. 142(Pt B). 113213–113213. 6 indexed citations
2.
Lin, Tuo, Jinyuan Liu, Ruifeng Chen, et al.. (2024). A doubly robust estimator for the Mann Whitney Wilcoxon rank sum test when applied for causal inference in observational studies. Journal of Applied Statistics. 51(16). 3267–3291. 1 indexed citations
3.
4.
Chen, Ruifeng, John P. Pierce, Eric C. Leas, et al.. (2022). Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019. Tobacco Control. 32(e2). e145–e152. 54 indexed citations
5.
Chen, Siyun, et al.. (2022). Effectiveness and Success Factors of Bilateral Arm Training After Stroke: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience. 14. 875794–875794. 13 indexed citations
6.
Dennis, Michael J., Assuntina G. Sacco, Yuchen Qi, et al.. (2022). A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma. Oral Oncology. 135. 106219–106219. 13 indexed citations
7.
Baumgartner, Joel, Ruifeng Chen, Karen Messer, et al.. (2022). Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial. Journal of the American College of Surgeons. 235(5). 693–701. 5 indexed citations
8.
Chen, Ruifeng, et al.. (2022). Patient Blood Type Is Associated With Response to Immune Checkpoint Blockade in Metastatic Cancer. The Oncologist. 27(9). e739–e747. 1 indexed citations
9.
Chapelin, Fanny, Benjamin I. Leach, Ruifeng Chen, et al.. (2021). Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with 19F MRI in a Murine Model. Radiology Imaging Cancer. 3(1). e200062–e200062. 9 indexed citations
10.
Sacco, Assuntina G., Ruifeng Chen, Francis P. Worden, et al.. (2021). Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. The Lancet Oncology. 22(6). 883–892. 174 indexed citations breakdown →
11.
Pierce, John P., Ruifeng Chen, Eric C. Leas, et al.. (2021). Use of E-cigarettes and Other Tobacco Products and Progression to Daily Cigarette Smoking. PEDIATRICS. 147(2). 60 indexed citations
12.
Pierce, John P., David R. Strong, Matthew D. Stone, et al.. (2020). Real-world exposure to graphic warning labels on cigarette packages in US smokers: The CASA randomized trial protocol. Contemporary Clinical Trials. 98. 106152–106152. 6 indexed citations
13.
Shatsky, Rebecca, Richard B. Schwab, Teresa Helsten, et al.. (2020). Abstract P3-10-18: Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer. Cancer Research. 80(4_Supplement). P3–10. 4 indexed citations
14.
Chen, Ruifeng, Meng Wang, Qiang Liu, et al.. (2019). Sequential treatment with aT19 cells generates memory CAR-T cells and prolongs the lifespan of Raji-B-NDG mice. Cancer Letters. 469. 162–172. 7 indexed citations
15.
16.
17.
Bai, Long, Wenjie Ge, Xiaohong Chen, & Ruifeng Chen. (2012). Design and Dynamics Analysis of a Bio-Inspired Intermittent Hopping Robot for Planetary Surface Exploration. International Journal of Advanced Robotic Systems. 9(4). 10 indexed citations
18.
Chen, Ruifeng & Velusamy Subramaniam. (2011). Increasing production rate in Kanban controlled assembly lines through preventive maintenance. International Journal of Production Research. 50(4). 991–1008. 18 indexed citations
19.
Chen, Ruifeng, et al.. (2008). PREPARATION OF ALUMINA SLURRIES WITH LOW VISCOUS AND HIGH SOLID LOADING BY DIFFERENT PARTICLE SIZE MIXING METHOD. 1 indexed citations
20.
Chen, Ruifeng, et al.. (2000). Modified adaptive feedforward runout compensation for dual-stage servo system. IEEE Transactions on Magnetics. 36(5). 3581–3584. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wojciech Dudek Breakdown of academic impact, for papers by Sijian Zhang Breakdown of academic impact, for papers by Suren Krishnan Breakdown of academic impact, for papers by Chengshui Chen Breakdown of academic impact, for papers by Gordon McKenzie Breakdown of academic impact, for papers by Yuan Tan Breakdown of academic impact, for papers by Man‐Yee Chan Breakdown of academic impact, for papers by Kandice Mah Breakdown of academic impact, for papers by Gary W. Chien Breakdown of academic impact, for papers by Chunpeng Fan
Rankless by CCL
2026